IPO Trending
CHCLSME / BSEListed
Cian Healthcare

Cian Healthcare Limited, incorporated in 2003, is a multinational manufacturing company certified by WHO-GMP and ISO 9001:2015, specializing in food supplements, sexual wellness, cosmeceuticals, nutraceuticals, ayurvedic, and pharmaceutical products. The company develops, manufactures, and commercializes products across 12 therapeutic divisions and 10 sales divisions, operating under its own brand while also engaging in government supplies, exports, and third-party manufacturing. Its product portfolio includes sachets, gels, lotions, creams, ointments, liquid orals, capsules, and tablets, and it holds a special license to manufacture veterinary products such as Venky's and SAVAvet. As of March 31, 2018, sales were comprised of 37% contract manufacturing, 24% government supplies, 23% franchise business, and 16% export sales.

₹61 - ₹65Open
Listed Price₹62.00
Listing Gain-4.62%

Subscription Status

0Updated 20 Oct 2026, 01:30 AM
Subscription PendingExchange subscription breakup is not available yet.

Category-wise demand has not been published yet. Check back after the exchange updates the live subscription feed.

Open Date02 May 2019
Close Date15 May 2019
Listing Date23 May 2019
Bidding status cross-verified with live IPO subscription numbers ↗BSE & NSE Bidding Portal Feed

About Cian Healthcare IPO Subscription Demand

Live subscription status and bidding analysis for Cian Healthcare (CHCL) IPO. The issue is subscribed Tracking Live overall across Qualified Institutional Buyers (QIB), Non-Institutional Investors (NII/HNI), and Retail Individual Investors (RII). Check real-time grey market demand on our GMP Tracker or review full issue details, lot size, and price band on the IPO Details Page.

Frequently Asked Questions